endocrinologists dermatologists collaboration glp-1 care GLP-1s aren't just changing weight management, they're showing up in the dermatology clinic. Various cutaneous effects and evolving inflammatory skin disease patterns are all part of the conversation. Swipe to learn the Your Patient Is on a

Conclusions This study explored the relationship between GLP-1RAs and SSIBs through disproportionality analysis

Oral semaglutide demonstrates this possibility, even with only about one percent absorption

A thorough weight history, assessment of volume status and use of three essential tests (blood pressure, estimated glomerular filtration rate and spot urine albumin to creatinine ratio) are imperative to the diagnosis of CKD

MEDVis semaglutide program emphasizes performance consistency rather than comparative marketing

Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes